Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01633060 | A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi(BELLE-3) | terminated | Phase 3 | 432 | Novartis PharmaceuticalsINDUSTRY | 22 | Jan 30, 2019 | clinicaltrials |
| NCT02067884 | Contrast Enhanced Ultrasound and Shear Wave Elastography in Measuring Response in Patients With Breast Cancer Receiving Chemotherapy Before Surgery | terminated | Phase 1 | 34 | University of Southern CaliforniaOTHER |
| 1 |
| Jan 25, 2019 |
| clinicaltrials |
| NCT00096369 | Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer | terminated | Phase 2 | 130 | University of Texas Southwestern Medical CenterOTHER | 1 | Jan 24, 2019 | clinicaltrials |
| NCT01185509 | Trastuzumab and Vinorelbine in Advanced Breast Cancer | terminated | Phase 2 | 31 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT02299635 | A Study Evaluating PF-03084014 In Patients With Advanced Breast Cancer With Or Without Notch Alterations | terminated | Phase 2 | 19 | PfizerINDUSTRY | 6 | Jan 8, 2019 | clinicaltrials |
| NCT03316794 | A Study of SC-005 in Subjects With Triple Negative Breast Cancer (TNBC) | terminated | Phase 1 | 2 | AbbVieINDUSTRY | 1 | Dec 17, 2018 | clinicaltrials |
| NCT01912963 | Phase II Study of Eribulin Mesylate, Trastuzumab, and Pertuzumab in Women With Metastatic, Unresectable Locally Advanced, or Locally Recurrent HER2-Positive Breast Cancer | terminated | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 5, 2018 | clinicaltrials |
| NCT03070002 | Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells | terminated | Phase 2 | 1 | Northwestern UniversityOTHER | 1 | Nov 20, 2018 | clinicaltrials |
| NCT02347163 | Pre-operative Zoledronate in Triple Negative Breast Cancer | terminated | Phase 2 | 22 | Mario Negri Institute for Pharmacological ResearchOTHER | 1 | Nov 6, 2018 | clinicaltrials |
| NCT02669914 | MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors | terminated | Phase 2 | 4 | Washington University School of MedicineOTHER | 1 | Nov 6, 2018 | clinicaltrials |
| NCT00214149 | Multi-catheter High Dose Rate (HDR) Breast Brachytherapy | terminated | Phase 2 | 127 | University of Wisconsin, MadisonOTHER | 1 | Nov 5, 2018 | clinicaltrials |
| NCT02375048 | Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: WBI Versus APBI | terminated | Phase 2 | 179 | Istituto Clinico HumanitasOTHER | 1 | Oct 24, 2018 | clinicaltrials |
| NCT00584012 | A Study of the Proper Dosage of Lovastatin and Docetaxel for Patients With Cancer | terminated | Phase 1 | 9 | Susan L RoederOTHER | 1 | Oct 19, 2018 | clinicaltrials |
| NCT00651976 | Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery | terminated | Early Phase 1 | 213 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Oct 15, 2018 | clinicaltrials |
| NCT02297230 | Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular Characteristics | terminated | Phase 1 / Phase 2 | 44 | NYU Langone HealthOTHER | 1 | Oct 15, 2018 | clinicaltrials |
| NCT03089502 | Efficacy of Cardio-Oncology Rehabilitation Exercise for Women With Breast Cancer and Treatment Related Cardiotoxicity(CORE) | terminated | N/A | 2 | University Health Network, TorontoOTHER | 1 | Oct 12, 2018 | clinicaltrials |
| NCT03358004 | the Role of Two Different Metronomic Chemotherapy Regimens in Locally Advanced or Metastatic Triple Negative Breast Cancer Patients (TNBC) as Maintenance Therapy After First Line Treatment(VICTOR3) | terminated | Phase 2 | 4 | Mario Negri Institute for Pharmacological ResearchOTHER | 3 | Oct 5, 2018 | clinicaltrials |
| NCT03648983 | Arm Circumference Measurement With or Without Bioimpedance Spectroscopy in Finding Lymphedema Early in Patients With Stage I-III Breast Cancer | terminated | N/A | 95 | Albert Einstein College of MedicineOTHER | 1 | Oct 1, 2018 | clinicaltrials |
| NCT00193726 | Estrogen Priming to Increase the Efficacy of Adjuvant Chemotherapy in Operable Breast Cancer | terminated | Phase 3 | 273 | Sudeep GuptaOTHER_GOV | 1 | Sep 20, 2018 | clinicaltrials |
| NCT02650635 | TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors | terminated | Phase 1 | 4 | Mayo ClinicOTHER | 1 | Sep 5, 2018 | clinicaltrials |
| NCT01035268 | Adipose Tissue Transfer for Moderate Breast Cancer Conservative Treatment Sequella(GRATSEC) | terminated | Phase 3 | 196 | Institut Claudius RegaudOTHER | 1 | Aug 22, 2018 | clinicaltrials |
| NCT02364960 | Targeted Intraoperative Therapy Registry at Bethesda North Hospital (TARGIT)(TARGIT) | terminated | — | 16 | TriHealth Inc.OTHER | 1 | Aug 22, 2018 | clinicaltrials |
| NCT01690325 | Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON) | terminated | Phase 2 | 21 | Women's Cancer Study Group GmbHOTHER | 1 | Aug 13, 2018 | clinicaltrials |
| NCT00088972 | S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women | terminated | Phase 2 | 8 | SWOG Cancer Research NetworkNETWORK | 1 | Aug 10, 2018 | clinicaltrials |
| NCT02694380 | Measuring the Effect of Radiation Therapy on Patient Activity Levels | terminated | — | 32 | University of PittsburghOTHER | 1 | Aug 9, 2018 | clinicaltrials |
| NCT01051401 | Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer | terminated | Phase 1 | 5 | Wake Forest University Health SciencesOTHER | 1 | Aug 1, 2018 | clinicaltrials |
| NCT00225758 | Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy | terminated | Phase 2 | 27 | Gary SchwartzOTHER | 1 | Jul 27, 2018 | clinicaltrials |
| NCT01394211 | Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer | terminated | Phase 2 | 2 | University of ArizonaOTHER | 1 | Jul 26, 2018 | clinicaltrials |
| NCT00852332 | Docetaxel With or Without a Phytochemical in Treating Patients With Breast Cancer | terminated | Phase 2 | 42 | Centre Jean PerrinOTHER | 1 | Jul 24, 2018 | clinicaltrials |
| NCT00169104 | Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function | terminated | Phase 2 / Phase 3 | 23 | Dartmouth-Hitchcock Medical CenterOTHER | 0 | Jul 20, 2018 | clinicaltrials |
| NCT03073473 | Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers | terminated | — | 40 | Cota Inc.INDUSTRY | 1 | Jul 20, 2018 | clinicaltrials |
| NCT01388777 | Cryoablation for Invasive Breast Carcinoma Following Neoadjuvant Therapy | terminated | Phase 2 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 17, 2018 | clinicaltrials |
| NCT02455882 | Tissue Procurement Protocol for Patients Undergoing Treatment for Early-Stage Breast Cancer | terminated | — | 14 | University of MichiganOTHER | 1 | Jul 12, 2018 | clinicaltrials |
| NCT00088829 | Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer | terminated | Phase 2 | 22 | Georgetown UniversityOTHER | 1 | Jul 11, 2018 | clinicaltrials |
| NCT01009983 | Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer | terminated | Phase 2 | 14 | Wake Forest University Health SciencesOTHER | 1 | Jul 6, 2018 | clinicaltrials |
| NCT02023008 | Interactive Gentle Yoga in Improving Quality of Life in Patients With Stage I-III Breast Cancer Undergoing Radiation Therapy | terminated | N/A | 6 | Wake Forest University Health SciencesOTHER | 1 | Jul 2, 2018 | clinicaltrials |
| NCT02331251 | Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus) | terminated | Phase 1 / Phase 2 | 81 | Western Regional Medical CenterOTHER | 1 | Jul 2, 2018 | clinicaltrials |
| NCT01580800 | National Breast Cancer and Lymphedema Registry | terminated | — | 549 | Stanley RocksonOTHER | 1 | Jun 29, 2018 | clinicaltrials |
| NCT03407430 | Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain | terminated | Phase 2 | 11 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jun 26, 2018 | clinicaltrials |
| NCT02281812 | Radiofrequency Ablation in Breast Cancer | terminated | N/A | 40 | Hospital Universitari de BellvitgeOTHER | 1 | Jun 4, 2018 | clinicaltrials |
| NCT00827580 | Eniluracil Hand Foot Syndrome | terminated | Phase 1 | 3 | West Virginia UniversityOTHER | 1 | May 30, 2018 | clinicaltrials |
| NCT02524951 | Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer | terminated | Phase 1 | 5 | Northwell HealthOTHER | 1 | May 18, 2018 | clinicaltrials |
| NCT01776008 | Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer | terminated | Phase 2 | 16 | National Cancer Institute (NCI)NIH | 1 | May 8, 2018 | clinicaltrials |
| NCT02543645 | A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer | terminated | Phase 1 | 18 | Celldex TherapeuticsINDUSTRY | 1 | Apr 30, 2018 | clinicaltrials |
| NCT02379585 | Fasting on Newly Diagnosed Breast Cancer(STEFNE) | terminated | Phase 1 / Phase 2 | 8 | Western Regional Medical CenterOTHER | 1 | Apr 24, 2018 | clinicaltrials |
| NCT00898937 | Gene Expression in Tumor Tissue From Women Undergoing Surgery for Breast Cancer or Core Biopsy of the Breast | terminated | — | 55 | Georgetown UniversityOTHER | 1 | Apr 13, 2018 | clinicaltrials |
| NCT02365714 | CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI)(CK-SAPBI) | terminated | Phase 1 / Phase 2 | 2 | Georgetown UniversityOTHER | 1 | Apr 13, 2018 | clinicaltrials |
| NCT00824538 | Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone Marrow | terminated | Phase 2 | 13 | University of California, San FranciscoOTHER | 0 | Apr 5, 2018 | clinicaltrials |
Data updated 23 days agoSource updated Jan 30, 2019source: clinicaltrials